Quantcast
Tag archive for ‘meningococcal disease’
By The Dispatch On Monday, April 7th, 2014
0 Comments

Bexsero, meningitis B vaccine, receives FDA Breakthrough Therapy designation

PRESS RELEASE Novartis announced today that Bexsero® (Meningococcal Group B Vaccine [rDNA, component, adsorbed]) has received a Breakthrough Therapy designation from the United States Food and Drug Administration More...

By Robert On Monday, December 2nd, 2013
2 Comments

UC Santa Barbara reports fourth case of meningococcal disease

A fourth University of California, Santa Barbara (UCSB) undergraduate student has been confirmed positive for meningococcal disease, according to a Santa Barbara County Public Health Department (PHD)  press release More...

By Robert On Wednesday, November 27th, 2013
1 Comment

UC Santa Barbara freshman, Aaron Loy, has feet amputated due to meningococcal disease

The University of California, Santa Barbara meningitis outbreak affected three students in recent weeks, in which two have recovered and returned to school. However, one student, a lacrosse player from Carlsbad, More...

By Robert On Tuesday, November 26th, 2013
2 Comments

Princeton announces dates for receiving meningitis B vaccine

The New Jersey university, which has experienced eight cases of  serogroup B meningococcal disease since March, has announced the dates they will be administering the vaccine that helps protect against meningococcal More...

By Robert On Monday, August 5th, 2013
0 Comments

FDA approves Menveo quadrivalent meningococcal vaccine in children starting as early as two months

The Food and Drug Administration (FDA) approved the expanded age range for Menveo quadrivalent meningococcal vaccine for infants and toddlers from 2 months of age, according to a FDA approval letter. Neisseria More...

By Robert On Thursday, January 24th, 2013
1 Comment

Bexsero, first Meningitis B vaccine, receives European Commission approval

Photo/CDC/ Debora Cartagena Switzerland-based pharmaceutical and health care company, Novartis announced this week that it’s Meningitis B vaccine, Bexsero, has received approval from the European Commission More...


Recent Posts


DISPATCH BLOGS

Splash Page logo 300x146 Today in History